As the biochemical hallmarks of FHH are elevated calcium and PTH levels, the main differential diagnosis for FHH is primary hyperparathyroidism (PHPT), a condition that is ultra-rare in pediatric patients and has never been reported in neonates [51]. The gene discussed is PTH; the disease is familial hypocalciuric hypercalcemia.